A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Clinical trial NCT05565742 · COMPLETED

Trial details

NCT number: NCT05565742
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lipoprotein Disorder

Start date: 2022-10-20
Primary completion: 2023-10-23
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.